CLINICAL_TRIALS
trial_result
· 2021-07-06
Clinical Trial Update: Efficacy and Safety of Nitrazine in the Treatment of ALS [Phase 2]
Summary
Phase 2 clinical trial update on Nitrazine for amyotrophic lateral sclerosis, reporting on efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking University Third Hospital | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: UNKNOWN